ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07624
-0,09%
Bitcoin
63.701,01
-0,30%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Europa
  5. EU
  6. Galapagos (GLPG)

  7. Galapagos (GLPG) News

GLPG

Galapagos (GLPG)

Galapagos
Von:
Sortieren nach:
 Showing the most relevant articles for your search:EU:GLPG
DatumZeitQuelleÜberschriftSymbolFirma
02/05/202422h01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
02/05/202422h01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
30/04/202422h01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
30/04/202422h01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
04/04/202422h01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
04/04/202422h01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
28/03/202421h01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
28/03/202421h01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
26/03/202421h01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
26/03/202421h01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
22/02/202422h01GlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024EU:GLPGGalapagos
22/02/202422h01GlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024EU:GLPGGalapagos
15/02/202422h01GlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024EU:GLPGGalapagos
15/02/202422h01GlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024EU:GLPGGalapagos
31/01/202422h01GlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
31/01/202422h01GlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
04/01/202422h44Dow Jones NewsGalapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer DrugEU:GLPGGalapagos
04/01/202422h01GlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
04/01/202422h01GlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
03/01/202422h01GlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyEU:GLPGGalapagos
03/01/202422h01GlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyEU:GLPGGalapagos
02/01/202407h00GlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
02/01/202407h00GlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
19/12/202322h01GlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301EU:GLPGGalapagos
19/12/202322h01GlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301EU:GLPGGalapagos
09/12/202318h00GlobeNewswire Inc.Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101EU:GLPGGalapagos
09/12/202318h00GlobeNewswire Inc.Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101EU:GLPGGalapagos
07/12/202322h01GlobeNewswire Inc.Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023EU:GLPGGalapagos
07/12/202322h01GlobeNewswire Inc.Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023EU:GLPGGalapagos
02/11/202321h01GlobeNewswire Inc.Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023EU:GLPGGalapagos
 Showing the most relevant articles for your search:EU:GLPG

Kürzlich von Ihnen besucht

TG
DTE
Deutsche Telekom
TG
BAS
BASF
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
NYSE
XOM
Exxon Mobil
DBI
DAX
DAX
FX
EURGBP
Euro vs Sterling
CCOM
US500
US 500
USOTC
ADDYY
Adidas (QX)
TG
CBK
Commerzbank
USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
NASDAQ
MSFT
Microsoft
AMEX
SPY
SPDR S&P 500
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten